Compare WRBY & LMAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | WRBY | LMAT |
|---|---|---|
| Founded | 2010 | 1983 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Ophthalmic Goods | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.6B | 2.6B |
| IPO Year | 2021 | 2006 |
| Metric | WRBY | LMAT |
|---|---|---|
| Price | $24.51 | $99.96 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 11 | 5 |
| Target Price | $27.10 | ★ $105.80 |
| AVG Volume (30 Days) | ★ 3.2M | 214.4K |
| Earning Date | 05-07-2026 | 05-05-2026 |
| Dividend Yield | N/A | ★ 0.93% |
| EPS Growth | ★ 105.88 | 30.57 |
| EPS | 0.03 | ★ 0.68 |
| Revenue | ★ $871,905,000.00 | $249,602,000.00 |
| Revenue This Year | $14.48 | $14.21 |
| Revenue Next Year | $16.41 | $8.88 |
| P/E Ratio | $813.33 | ★ $149.12 |
| Revenue Growth | 13.04 | ★ 13.53 |
| 52 Week Low | $14.96 | $78.35 |
| 52 Week High | $31.00 | $118.01 |
| Indicator | WRBY | LMAT |
|---|---|---|
| Relative Strength Index (RSI) | 47.51 | 38.23 |
| Support Level | $21.22 | $82.65 |
| Resistance Level | $28.87 | $99.95 |
| Average True Range (ATR) | 2.39 | 4.80 |
| MACD | -0.21 | -0.64 |
| Stochastic Oscillator | 34.44 | 20.90 |
Warby Parker Inc is a mission-driven, lifestyle brand that operates at the intersection of design, technology, healthcare, and social enterprise. The Company provides holistic vision care by offering eyewear, contacts, and eye care directly to consumers through its integrated, omnichannel platform. The company predominantly derives revenue from the sales of eyewear products, optical services, and accessories. The firm sells products and services through its stores, website, and mobile apps. Revenue generated from eyewear products includes the sales of prescription and non-prescription optical glasses and sunglasses, contact lenses, eyewear accessories, and expedited shipping charges.
LeMaitre Vascular Inc is a provider of medical devices and human tissue cryopreservation services mainly used in the treatment of peripheral vascular disease, end-stage renal disease, and cardiovascular disease. The company develops, manufactures, and markets vascular devices to address the needs of vascular surgeons and, to a lesser extent, other specialties such as cardiac surgeons, general surgeons, and neurosurgeons. Its diversified portfolio consists of branded products used in arteries and veins that are well known to vascular surgeons. It operates across the Americas, Europe, the Middle East and Africa, and Asia Pacific, with the majority of its revenue generated from the Americas.